Article references (29 references )

  1. Lee WM. Medical Progress: Hepatitis B Virus infection: review articles. N Engl J Med. 1997; 337: 1733-1745. Google Scholar

  2. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet. 1993 Nov 27; 342(8883): 1340-4. PubMed | Google Scholar

  3. Zampino R, Boemio A, Sagnelli C. hepatitis B virus burden in developing countries. World J Gastroenterol. 2015; 21(42): 11941-11953. PubMed | Google Scholar

  4. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007; 37(s1): S9-S19. PubMed | Google Scholar

  5. Kondili LA, Genovese D, Argentini C, Chionne P, Toscani P, Fabro R, Cocconi R et al. Nosocomial transmission in simultaneous outbreaks of hepatitis C and B virus infections in a haemodialysis center. Eur J Clin Microbiol Infect Dis. 2006; 25(8): 527-531. PubMed | Google Scholar

  6. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C et al. Patterns of hepatitis B prevalence and Seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003; 63(6): 2222-2229. PubMed | Google Scholar

  7. Peces R, De La Torre M, Alcazar R, Urra JM. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Am J Kidney Dis. 1997; 29(2): 239-245. PubMed | Google Scholar

  8. Grzegorzewska AE. Prophylactic vaccinations in chronic kidney disease: Current status. Hum Vaccine Immunother. 2015; 11(11): 2599-2605. PubMed | Google Scholar

  9. Rangel MC, Coronado VG, Euler GL, Strikas RA. Vaccine recommendations for patients on chronic dialysis. Semin Dial. 2000;13(2):101-107. PubMed | Google Scholar

  10. Sit D, Esen B, Atay AE, Kayabasi H. Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy. World World J Hepatol. 2015 Apr 18: 7(5): 761-768. PubMed | Google Scholar

  11. Tele SA, Martins RM, Lopes CL, dos Santos Carneiro MA, Souza KP et al. Immunogenicity of a recombinant hepatitis B vaccine (Euvax-B) in haemodialysis patients and staff. Eur J Epidemiol. 2001; 17(2): 145-149. PubMed | Google Scholar

  12. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Vaccine. 2004; 22(29-30): 3963-3967. PubMed | Google Scholar

  13. Igetei R, Awobusuyi JO, Wright OK, Olaleye DO. Occult Hepatitis B Virus Infection in Nigerian Patients on Hemodialysis. Trop J Nephrol. 2015; 10(2): 79- 85. Google Scholar

  14. Bernieh B. Viral hepatitis in hemodialysis: An update. J Transl Intern Med. 2015; 3(3): 93-105. PubMed | Google Scholar

  15. Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl. 2003 Feb; 83: S119-22. PubMed | Google Scholar

  16. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney IntSuppl. 2013; 3: 1-150. Google Scholar

  17. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999; 179(2): 489-492. PubMed | Google Scholar

  18. Boumansour N, Midoun N. Vaccination préventive contre l'hépatite virale B chez les insuffisants rénaux chroniques à Oran, Algérie. Revue d'épidémiologie et de santé publique. September 2014; 62(5): S231.

  19. Feriani H, Chaker H, Habib S, Aguerbi I, Toumi S, Mnif Ket al. Vaccination intradermiquecontrel'hépatite B chez les hémodialyséschroniques. Nephrol Ther. 2015; 11(5): 327. Google Scholar

  20. Ibrahim S, El-din S, Bazzal. Antibody level after Hepatitis-B vaccination in Hemodialysis Patients: Impact of Dialysis Adequacy, Chronic Inflammation, Local Endemicity and Nutritional Status. J Natl Med Assoc. 2006; 98(12):1953-7. PubMed | Google Scholar

  21. Ayub MA, Bacci MR, Fonseca FLA, Chehter EZ. Hemodialysis and hepatitis B vaccination: a challenge to physicians. Int J Gen Med. 2014; 7: 109-114. PubMed | Google Scholar

  22. Schiller A, Timar R, Siriopol D, Timar B, Bob F, Schiller O et al. Hepatitis B and C virus infection in the hemodialysis population from three Romanian regions. Nephron. 2015; 129(3): 202-8. PubMed | Google Scholar

  23. Grzegorzewska AE. Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients. Hepat Mon. 2012; 12(11): e7359. PubMed | Google Scholar

  24. Crosnier J, Jungers P, Courouce A, Laplanche A, Benhamou E, Degos F et al. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units. Lancet. 1981 Apr 11; 1(8224): 797-800. PubMed | Google Scholar

  25. Schiffl H, Lang S, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001; 16(9): 1863-1869. PubMed | Google Scholar

  26. Kaysen G. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol. 2001; 12(7): 1549-1557. PubMed | Google Scholar

  27. Fernandez E, Betriu MA, Gomez R, Montoliu J. Response to the hepatitis B virus vaccine in hemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant. 1996; 11(8): 1559-1563. PubMed | Google Scholar

  28. Kovacic V, Sain M, Vukman V. Efficient haemodialysis improves the response to hepatitis B virus vaccination. Intervirology. 2002; 45(3):172-176. PubMed | Google Scholar

  29. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol. 2002; 58(4): 301-304. PubMed | Google Scholar